Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Depreciation & Amortization (CF): 2019-2024

Historic Depreciation & Amortization (CF) for Praxis Precision Medicines (PRAX) over the last 6 years, with Dec 2024 value amounting to $400,000.

  • Praxis Precision Medicines' Depreciation & Amortization (CF) fell 79.35% to $19,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $201,000, marking a year-over-year decrease of 52.37%. This contributed to the annual value of $400,000 for FY2024, which is 7.41% down from last year.
  • As of FY2024, Praxis Precision Medicines' Depreciation & Amortization (CF) stood at $400,000, which was down 7.41% from $432,000 recorded in FY2023.
  • Over the past 5 years, Praxis Precision Medicines' Depreciation & Amortization (CF) peaked at $432,000 during FY2023, and registered a low of $50,000 during FY2020.
  • In the last 3 years, Praxis Precision Medicines' Depreciation & Amortization (CF) had a median value of $419,000 in 2022 and averaged $417,000.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first soared by 300.00% in 2021, then dropped by 7.41% in 2024.
  • Praxis Precision Medicines' Depreciation & Amortization (CF) (Yearly) stood at $50,000 in 2020, then skyrocketed by 300.00% to $200,000 in 2021, then spiked by 109.50% to $419,000 in 2022, then climbed by 3.10% to $432,000 in 2023, then declined by 7.41% to $400,000 in 2024.